Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial

DSpace Repository

Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial

Author: Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lueftner, Diana; Busse, Antonia
Tübinger Autor(en):
Brucker, Sara
Published in: European Journal of Cancer (2022), Bd. 162, S. 45-55
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2021.11.025
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)